Number (%) of participants achieving the minimum clinically important increase of 20 points or more in VISA-A scores from baseline over time by treatment group
| Treatment group | 6 wk, n (%) | 3 mo, n (%) | 6 mo, n (%) | 12 mo, n (%) |
|---|---|---|---|---|
| ELE (n=15) | 3 (20) | 8 (53) | 7 (47) | 11 (73) |
| Prolotherapy (n=14) | 5 (36) | 7 (50) | 11 (79) | 11 (79) |
| Combined treatment (n=14) | 7 (50) | 8 (57) | 10 (71) | 12 (86) |